Tamiflu use extended

The lower age limit for use of Tamiflu (oseltamivir) has been reduced from one year to six months of age when treating flu during a pandemic. Prophylactic use of the drug is not recommended under one year. The capsule SPCs now also provide instructions for preparing extemporaneous oral 10mg/ml or 15mg/ml solutions from capsules when the powder for oral suspension is unavailable.

View Tamiflu drug record

Further information: Roche


To sign up for the MIMS monthly news update, register at www.mims.co.uk/bulletins.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Compare COVID-19 vaccines with new MIMS table

Compare COVID-19 vaccines with new MIMS table

Key characteristics of available COVID-19 vaccines...

Deleted products - live tracker

Deleted products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products removed...

Drug price changes - live tracker

Drug price changes - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...